| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals International, Plc (KNSA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. KNSA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.2K | $34.51M | - | |
| Other | 143.9K | $7.93M | - | |
| Dir | 36.5K | $2.01M | - | |
| COO | 28.7K | $1.58M | - | |
| CFO | 22.8K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | Tessari Eben | Chief Operating Officer | Sale+OE | 17,500 | $24.99 | $437,325.00 | -13.0% | -17.7% | +47.6% | |
| Sep 3, 2024 | Paolini John F.51 | Chief Medical Officer | Sale+OE | 60,692 | $26.12 | $1,584,991.40 | -36.5% | -16.0% | +36.4% | |
| Sep 3, 2024 | Moat Ross | Chief Commercial Officer | Sale+OE | 68,506 | $26.12 | $1,789,189.80 | -60.6% | -16.0% | +36.4% | |
| Aug 27, 2024 | Tessari Eben | Chief Operating Officer | Sale+OE | 17,500 | $26.91 | $470,925.00 | -12.7% | -19.4% | +24.5% | |
| Jul 23, 2024 | Patel Sanj K | Chairman &CEO | Sale+OE | 136,124 | $25.65 | $3,491,947.24 | -27.2% | -1.5% | +3.2% | |
| Jul 23, 2024 | Ragosa Mark | Chief Financial Officer | Sale+OE | 24,248 | $24.79 | $601,107.92 | -55.7% | -1.5% | +3.2% | |
| Jul 23, 2024 | Paolini John F.51 | Chief Medical Officer | Sale+OE | 22,000 | $26.32 | $578,966.14 | -9.2% | -1.5% | +3.2% | |
| Mar 7, 2024 | Patel Sanj K | Chairman &CEO | Sell | 65,012 | $21.02 | $1,366,552.24 | -100% | -7.3% | +1.2% | |
| Mar 6, 2024 | Patel Sanj K | Chairman &CEO | Sell | 18,324 | $21.34 | $391,055.86 | -8.0% | -8.0% | +1.3% | |
| Mar 1, 2024 | Tessari Eben | Chief Operating Officer | Sale+OE | 1,189 | $22.03 | $26,193.67 | -1.0% | -14.6% | -6.7% |